Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Can Fingermotion Fngr Stock Maintain Growth Price At 0.88 Up 6.70 20260410 Ashok Leyland Q4 Profit Climbs 11 on Record Commercial Vehicle Volumes Novartis Lifts FullYear Guidance on Strong Operational Momentum Marvell Technology Stock Dips Despite Exceptional AI Demand Driving Accelerating Revenue Growth Outlook DeepSeek Chinese AI Model Impresses Silicon Valley with Limited Hardware Tulsi Gabbard Resigns as US National Intelligence Director Potential Implications for National Security and Defense Sector UK Spy Chief Warns of Moment of Consequence Geopolitical Risks Could Reshape Global Markets Volato Group Inc SOAR Q2 2025 Earnings Positive EPS Reported Amid Market Caution ARL Q3 2024 Earnings Loss Per Share Widens Amidst Challenging Real Estate Market NIQ Q1 2026 Earnings EPS Beats Estimates by 476 Amid Strong Operational Execution Edesa Biotech Inc EDSA Q1 2026 Earnings Wider Than Expected Loss as Clinical Pipeline Progresses ATNM Q1 2026 Earnings NarrowerthanExpected Loss Reflects Cost Discipline Amid IomabB Development Liberty AllStar Equity Fund Edges Higher Amid Steady Trading MBINM Holds Steady at 2575 Amid Low Volume as Preferred Shares Maintain Tight Range Xunlei XNET Edges Lower Amid Consolidation Near 544 Alliancebernstein Global High Income Fund AWF Edges Lower Amid Cautious Sentiment Orchid Island Capital ORC Edges Higher Approaches Key Resistance at 727 AEAQW Warrants Trade Flat at 038 as Price Consolidates Between Key Levels US Lawmakers Move to Allow Trumps Face on New 250 Bill Breaking Precedent Sachem Capital Corp SACH Q1 2026 Earnings Massive EPS Miss Stuns Market as Losses Widen Retirees May Misinterpret New 6000 Senior Tax Deduction Key Clarifications Deutsche Bank Q1 2026 Earnings Modest EPS Beat Fails to Lift Stock SCNX Q1 2026 Earnings Strong EPS Beat Driven by Cost Management JBS Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue KGS Q1 2026 Earnings EPS Surpasses Estimates by 109 FTDR Q1 2026 Earnings EPS Surpasses Estimates with 587 Beat